Author

A. Bochnakian

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:clustering· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Idica· 1 shared B. Jneid· 1 shared B. Malissen· 1 shared C. Sedlik· 1 shared D. G. Zisoulis· 1 shared D. Jury· 1 shared E. Djacoto· 1 shared E. Piaggio· 1 shared

Activity by Year

2017-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Idica

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cellular selectivity of STING stimulation determines priming of tumor-specific T cell responses

B. Jneid, A. Bochnakian, F. Delisle, E. Djacoto, J. Denizeau, C. Sedlik, F. Fiore, R. Kramer, I. Walters, S. Carlioz, B. Malissen, E. Piaggio, N. Manel

This study shows that targeting STING in dendritic cells with cGAMP-VLP enhances tumor-specific T cell responses and synergizes with PD1 blockade for tumor eradication, while synthetic CDN causes systemic T cell activation without specific T cell differentiation.

bioRxiv · Dec 1, 2021Immunology

miR-128 inhibits telomerase activity by targeting TERT mRNA

H. Guzman, K. Sanders, A. Idica, A. Bochnakian, D. Jury, I. Daugaard, D. G. Zisoulis, I. Pedersen

This paper identifies miR-128 as a novel telomerase inhibitor that directly targets TERT mRNA, reducing its expression in cancer cell lines.

bioRxiv · Oct 6, 2017Cancer Biology